August 22, 2013 — UAS LifeSciences (formally UAS Labs) is proud to announce its new and improved professional product line, Multi-Flora Probiotics. The company has revamped the products with a clearer system of function and patient use in addition to higher potencies and condition specific formulations. All products continue to use the company’s researched and proven proprietary strain, DDS-1.
The new line builds on the company’s long-standing high-quality standards including important characteristics such as non-dairy, non-GMO, gluten free and vegan and remains room temperature stable and acid & bile resistant.
Greg Leyer, PhD, the new chief science officer at UAS LifeSciences now provides the company leadership in science and direction for clinical research. UAS is making a major investment that will allow us to validate probiotic benefits and meet and exceed industry standards.
To accompany the new formulations also comes a brand new look. The packaging is as state-of-the-art and technology driven as the products inside. Of special benefit for qualified practitioners and their staffs is a new web presence to be released shortly after the show to access trainings by Dr. Leyer, published studies and probiotic industry updates.
Source: UAS LifeSciences, ddsprobio.com
